“Dreams don’t work unless we do” 👌🏻
Submitted my application for
#GIFellowship
!
Looking 👀 back, I won’t have done this without my terrific 🌟 mentors who supported and guided me along the way! 🫶🏻 their wisdom and inspiration have been a cornerstone ⛰️ in this journey!
“Mentorship is the key” So excited for
#ACG2024
!
Glad to have:
✅ Oral presentation in the Presidential Plenary Session 🏆
✅ Oral presentation in the IBD Plenary Session 🏅
✅ 30+ poster presentations (>12 as presenting author) + QI project 🤞🏻
Always and forever thankful
🥇 Honored and thrilled to receive the 2024
@AASLDFoundation
Emerging Liver Scholar Award 🥇
Excited for the opportunity to connect and share knowledge with
#liver
lovers 💪🏻
🎯This opportunity brings me one step closer to my dream of researching PSC-IBD
This wouldn’t be
I am thrilled to know that a total of 4 of my research won the
@AmCollegeGastro
Presidential Poster Award 🥇
🎯Colorectal cancer incidence is increasing in young population
🎯Colorectal syphilis review
🎯HCC Epidemiology and trends
🎯SSL detection rates in FIT-positive
Excited to attend the
@AASLDtweets
TLM 2024 as an Emerging Liver Scholar!
Honored to have:
✅Oral presentation
✅multiple poster presentations 🧑🏻🏫
🏅Emerging Liver Scholarship
AND to connect with colleagues from
@LiverFellow
as a Social Media Liaison 🏆
@AASLDFoundation
“Poster of distinction” Award 🥇
It is an honor to have another one of our projects recognized
@DDWMeeting
!
📍Prophylactic intubation in severe upper GI bleeding 🩸 is associated with a higher risk of mortality, cardiac complications, pneumonia, and aspiration.
Credits go to
Happy to share that and for the
#first
time, we published our paper in the prestigious
@AGA_CGH
on the disparities in chronic liver diseases and
#cirrhosis
mortality in the US 🇺🇸
🔑
📌Mortality is increasing mostly in young women
📌Non-hispanic White race are at increased
⛔️Publication alert 🚨
The first comprehensive GI match study EVER⭐️
🎯GI has the highest competitiveness ratio among IM specialties
🎯Only GI and PCCM achieved growth in applications
🎯Positive correlation between competitiveness and financial compensation
Special thank
New publication 🚨
A very important paper for all GI fellows and GI programs leaders ✋🏻
In this paper we evaluated the career plans of GI fellows in the US😎
Key 🔑 points:
📌 ⬆️ trends of private practice
📌 🔽 trends for academic practice or further training among GI
During our oral presentation about CRC incidence disparities
@DDWMeeting
✅
📍CRC incidence is mostly going up in White individuals <45
📍African Americans >45 has the largest decrease in CRC incidence for the last 20 years
@AasmaShaukatMD
@BilalMohammadMD
#DDW2024
“Gratitude is the fairest blossom which springs from the soul”
Thrilled and honored to announce my nomination for the prestigious
#SigmaXi
scientific research honor society, immense gratitude to my mentors whose guidance has been invaluable on this journey!
Since 1886, Sigma
Publication 🚨
I have been always interested in outcomes research 🧐 As part of my Master degree in Clinical Research
@UMKC
, we are always learning about epidemiology 🌎
Check this piece of art 🖼️ where we analyzed the burden of
#IBD
in the
#US
for the past 30 years!
Key
Publication alert 🚨
Happy to share our novel study that delves into CRC disparities, especially early onset CRC. Published in
@AGA_GHAdvances
🔑 points:
📌Women (<45) had a greater ⬇️ in CRC incidence than men
📌Northeast states had the greatest decrease in CRC incidence in
A very important study just published at
@IBDJournals
📍
In this novel and largest of its kind study we show 🔑
📌JAKi are effective in less than 50% of patients with chronic pouchitis
📌JAKi should not be considered as first line for patients with chronic pouchitis
I am amazed by the number of people who passed by to hear about this project, and I was expecting it would get that much attention and compliments! It objectively proved that GI is the most competitive specialty!
@mfalmeqdadi
@YazanAbboudMD
@fouadsjaber
#DDW2023
#GITwitter
Poster of Distinction 🥇
📍 primary NKF vs conventional ERCP cannulation
✅ NKF may be a better choice especially in those with high risk of PEP.
Always grateful to
@Bashar_Qumseya
for his support and mentorship. Thankful to the team
@NumanLaith
@MahMadi90
.
@DDWMeeting
45 is the new 50!
Time to promote colonoscopy screening to our patients and loved ones!
👇🏻 some of our work regarding CRC screening under the mentorship of
@AasmaShaukatMD
@BilalMohammadMD
Hot off the press 🔥 📣
Our 👁️🗨️ metanalysis about suprapapillary (inside) stents in the official journal of
@SAGES_Updates
@EAES_eu
Take home points 🔑:
📌no clinical success difference between iPS and iMS
📌pooled AEs 9.5%
📌most common AE is cholangitis (2.2%)
📌more
Introducing the 2024 Emerging Liver Scholars! 🤩 Huge congrats to Mustafa Al-Karaghouli, MD, MSc, Saqr Alsakarneh, MD, Romelia Barba, MD, and Isabelle S. Byers, MD.
Learn more about AASLD Foundation's 2024 awardees at
New Publication 🚨
Esophageal self-expandable metal stents 🔑
📌Most common device issues: stent activation, positioning, or separation problems (46.2%).
📌 Patient complications included dysphagia/odynophagia (10%), perforation, pain, and bleeding (each 7.6%).
📌 Compared to
⛔️ New Publication ⛔️
I am pleased to share our article on PSC outcomes under the supervision of the brilliant
@doctornikkid
It is always a pleasure to have genius mentor who supports and walks you through success ⭐️
#GITwitter
#MedTwitter
@Stanford_GI
@umkcIM
Hot of the press 🔥
✅EUS-HGS after failed ERCP 🔑
📌70 studies and 3527 patients analyzed
📌Clinical success 90.9%
📌Technical success 98.1%
📌 pooled rate of AEs 14.9% with bile leakage being the most common AE
Thankful to the great mentors
@BilalMohammadMD
and
I am very delighted to share that with you! Our article on Ischemic Reperfusion Injury after Liver transplantation has been accepted! I am very proud of our hard-working team!
#GITwitter
#MedTwitter
@umkcIM
#Researcher
Have you ever thought about the effect of
#Frailty
on inpatient outcomes of patients with IBD? 🤓
In this first of its kind 🌟 study we found that:
📌Frail individuals with IBD are at higher risk of mortality 🪦 (aOR=9)
📌Higher sepsis (aOR=27) and AKI (8.9)
📌Frail patients
I am happy to see our research in press!
This study objectively demonstrates the importance of changing and updating the policies for CRC screening and implementation of new measures to fight CRC!
Thanks to my great mentors
@BilalMohammadMD
@AasmaShaukatMD
for supporting me
Congratulations to two
@UMN_GIHep
faculty on winning the resident faculty teacher of the year award for their respective clinical sites!
⭐️Minneapolis VA:
@BilalMohammadMD
⭐️University of MN:
@LizzieAbyMD
Our faculty are grateful to teach amazing trainees!
#GITwitter
#MedEd
Making your
#DDW2024
schedule? 🤔
➡️Interested in healthcare disparities? or liver transplant?
Consider our presentation on Liver Transplant disparities in the US
@DDWMeeting
▶️When: Saturday, 5/18 at 2:45 pm
▶️Meet us in Hall 202 B
Bring your thoughtful questions with you!
Our hot of the press publication in the
@AmJGastro
🚨
Very important study for every GI physician 🤞🏻
Avoid the 👇🏻 to get adequate bowel prep before colonoscopy 👌🏻
🔑
📌 154 studies with 358,257 participants
📌 SD predictors of IBP: Medicaid insurance, obesity, 🚬, age≥65,
The paper version looks pretty 🤩
“If a fellow isn’t thankful for what he’s got, he isn’t likely to be thankful for what he’s going to get.”
@SigmaXiSociety
#GITwitter
#MedTwitter
Happy yo see my name beside the brilliant
@doctornikkid
on the prestigious
@AGA_GHAdvances
!
🔴 Diversity is needed in TH through:
📌 Mentorship programs
📌 Guidance and recruiting more URIMs
📌 Equitable opportunities for SGM applicants
#GITwitter
New publication 🚨
Happy to share our paper in
@AGA_GHAdvances
that evaluates the effect of
#Covid_19
pandemic on diversity in GI fellowship matching 🔍
🔑 findings:
📌Positive trends in women and DOs representation during the pandemic
📌Gender disparities persist
📌Further
🎉Very Happy to share that I matched at
@bcm_gihep
, extremely excited to embark on the next chapter of my life 🙌
Eternally grateful and thankful to my family, friends, mentors, colleagues and everyone who helped me and supported me during this journey🙏🙏
#meded
#GITwitter
🚨🚨
Glad to know that our work will be featured during the
@DDWMeeting
!
Liver transplantation is an important topic that requires attention 🏥
Please pass by our poster on Tuesday 5/21 to learn more about the effect of Frailty on LT 🔬
@RKaragozian
@mfalmeqdadi
@AbuassiMoe
It was really a great experience
@ACPMissouri
where I presented 2 posters from our work. I really appreciate our team work who made this possible. Here we go
@umkcIM
!
#internalmedicine
#GI
#IBD
burden series 2️⃣
In this paper we discuss the recent changes in the epidemiology of
#IBD
in the
#MENA
region 🌍
This paper means a lot to me! We were able to objectively identify
#disparities
in a region where objective data 📊 is too little 😥
Thankful to the guidance
Publication 🚨
I have been always interested in outcomes research 🧐 As part of my Master degree in Clinical Research
@UMKC
, we are always learning about epidemiology 🌎
Check this piece of art 🖼️ where we analyzed the burden of
#IBD
in the
#US
for the past 30 years!
Key
You have an IBD patient with stricture? 🤔
What to do? Endoscopic stricturotomy? 🧐
Check out our publication 👇🏻 to know more about its safety and efficacy ✅
#GITwitter
🚨 New Publication 🚨
Efficacy and Safety of Endoscopic Stricturotomy in Inflammatory Bowel Disease-Related Strictures: A Systematic Review and Meta-Analysis
✅ Technical success rate of 96.4%, and clinical success rate of 62%
🩸 Bleeding rate was 10.5% per patient, and the
I am very proud of our team for publishing 4 papers in the last 3 weeks!
Very interesting and hot topics 🔥
Links below ⬇️
1- Acute pancreatitis outcomes during the COVID-19 pandemic 😷
2- Autoimmune hepatitis outcomes in pregnancy 🤰🏻
3- Epidemiology of Rectal
“Healthcare systems are sustained by Quality Improvement” 🧗🏻
Honored to have my QI project selected as one of the best 2 QI projects at
@UMKC
School of Medicine 2024 QIPS day! 🥇
🎗️We had great success by reducing the inappropriate PPI prescriptions from 66% to 32% in a couple
This is very interesting! 🧐
Small molecules (Upadacitinib) is the most effective medx to achieve PRO-2 clinical remission as induction and maintenance therapy 🥇
📖:
PS mark you 📅 for our oral presentation during
#ACG2024
on Wednesday 10/30 -
#IBD
Our latest publication 🚨
🔑
📌CRC patients are at increased risk of breakthrough COVID-19 infections regardless of booster doses
📌CRC patients at increased risk of all-cause hospitalization 🏥
📌No difference in ICU admissions or death
Always thankful to the support of
New publication 🚨
Racial disparities in GI mortality is under estimated topic ⚰️
Key points 🔑
🎯Ethnicity: Hispanics are more likely to die from GI/COCID-19 than other ethnicities
🎯Race: Blacks has the highest mortality rates in the US
What can we do? Develop targeted
📢 New publication!
Excited to share our latest publication on the impact of overweight & obesity on health outcomes in the US from 1990 to 2021
Huge thanks to
@basilenjei
and all my incredible co-authors for their contributions!
@AHNIMres
#GITwitter
📢 Original Article: Hepatocellular Carcinoma Incidence and Mortality in the USA by Sex, Age, and Race: A Nationwide Analysis of Two Decades
✍️ Authors:
@YazanAbboudMD
,
@msalehsv
,
@AbbadiSaqer
and
@fouadsjaber
et al.
🔗Read more:
Healthcare Utilization, Costs and Other Outcomes of Peroral Endoscopic Myotomy (POEM) Versus Heller Myotomy in the Inpatient Management of Achalasia in The United States: A 2016 to 2020 Nationwide Study
📕Read Here: …
#GITwitter
#MedTwitter
#SurgTwitter
✅ Master of Science in clinical research
I couldn’t have done it without the support of my better half
@ned0o0o
, my family, and my mentors! This one is for my dad who always pushed me to be better, I wish you were here with us!
#UMKCGrad
#RooUp
#GITwitter
#MedTwitter
#IMresidents
: Join ACG and current
#GIfellows
for a special Virtual Grand Rounds for the
#FutureofGI
! GI & Hepatology Fellowship
@TheNRMP
Application – Tips & Tricks For Prospective Fellowship Applicants Wednesday, April 24 @ 8pm ET
Register ➡️
🚨🚨Congratulations to our friend, colleague, favorite
#GItwitter
contributor and the nicest person I know,
@BilalMohammadMD
on his wedding!🎊🥳🎉
Looking forward to more celebrations!!
Grateful! Huge thanks to:
• 🇸🇩🇶🇦🇺🇸 My loving family: my late father, wife, kids, mom, siblings
• Friends, mentors, residency program, patients, nurses, co-residents, and staff.
• Every fellowship program that opened doors for me.
Finally to my new
@MayoClinicGIHep
GI family
Happening now 🛑
@doctornikkid
giving great advices and mentorship to the young upcoming generation of gastroenterologists! Great advices and tricks that make things easier ✅
@AGA_Gastro
#DDW2023
Best of luck!
Have had the pleasure to work with this legend on many occasions, and every single time, I was impressed but his dedication, professionalism, and most importantly, kindness!
#CardioTwitter
I'm thrilled to be applying for
#Cardiology
fellowship! Deeply thankful for the unwavering support from my mentors and program throughout this journey. Looking forward to the upcoming interview season and the next steps in my career
#CardioTwitter
#Match2025
@StElizabethsMC
New publication 🚨
POEM vs Heller Myotomy? What do you prefer?
Here we provide you with 🔑 to help you decide:
🎯In the US, POEM is ⬆️ but HM is ⬇️
🎯No difference in hospital charges 💴 or length of stay 🏥
🎯HM causes less pneumonia 🫁 or pneumoperitoneum
🎯Same rates of
Getting ready for
#ACG2023
But SO proud of our 🔥 team of residents/fellows & special 📣 to 👇 7 super ⭐️s for their
@AmCollegeGastro
Research Awards!
✅ The ACG Lawlor Resident Award
@nataliejowilson
✅ 6 Presidential Abstract Awards
If you see them, plz give them kudos 🙏
More and more data supporting the use of Interleukin-12/23 and Interleukin-23 Inhibitors in treating
#UC
🤞🏻
Our most recent study 👇🏻 showing its safety and efficacy 👌🏻for UC patients 🤩
#GITwitter
#MedEd
#IBD
🚨New Publication 🚨
Efficacy and Safety of Interleukin-12/23 and Interleukin-23 Inhibitors for Ulcerative Colitis: A Systematic Review Ad Meta-Analysis of Randomized Controlled Trials
⚡️In 5 trials involving 1120 patients with moderate to severe UC, targeting IL-23 showed: